Context Therapeutics (NASDAQ:CNTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Context Therapeutics (CNTX) operate in?

Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Context Therapeutics Stock (NASDAQ: CNTX) stock price, news, charts, stock research, profile.

Open	$2.03
Close	$2.05
Volume / Avg.	217.13K / 246.39K
Day Range	$1.94 - $2.10
52 Wk Range	0.77 - 2.75
Market Cap	$149.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	1.54%
Days to Cover	2.48

Recent News

Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.

Avi Kapoor

Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session.

Avi Kapoor

Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not limited to possible sale/other disposition of assets.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jul

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.03
Close	$2.05
Volume / Avg.	217.13K / 246.39K
Day Range	$1.94 - $2.10
52 Wk Range	0.77 - 2.75
Market Cap	$149.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	1.54%
Days to Cover	2.48

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Context Therapeutics (CNTX) stock?

You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.

View our list of the best stock brokerages

Who are Context Therapeutics (CNTX) competitors?

Other companies in Context Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Rani Therapeutics Hldgs (NASDAQ:RANI), Telomir Pharmaceuticals (NASDAQ:TELO) and Trevi Therapeutics (NASDAQ:TRVI).

What is the forecast, or price target, for Context Therapeutics (CNTX) stock?

Context Therapeutics has a consensus price target of $7.63.

What is the current price for Context Therapeutics (CNTX)?

The stock price for Context Therapeutics (NASDAQ: CNTX) is $1.99 last updated November 12, 2024 at 4:00 PM EST.

Does Context Therapeutics (CNTX) pay a dividend?

There are no upcoming dividends for Context Therapeutics.

When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?

Context Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Context Therapeutics (CNTX) going to split?

There is no upcoming split for Context Therapeutics.

What sector and industry does Context Therapeutics (CNTX) operate in?

Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Context Therapeutics

Context Therapeutics (CNTX) Forecast